BRAF and cancer: The use of another cancer logical model, from [17], thus makes it possible to study the response to MEK inhibitors, insufficiently described in the previously studied model, but does not make it possible to recover the responses to BRAF inhibitors, in particular because of a less precise description, with a single RAF node representing both BRAF and CRAF genes (see supplemental information in the GitHub of the study).